Mexico Receives 1.35 Million COVID Vaccines from US
Mexico has received 1.35 million doses of the Johnson & Johnson, single-dose COVID-19 vaccine donated by the United States.
[June 15, 2021: Josh Shavit]
Mexico has received 1.35 million doses of the Johnson & Johnson, single-dose COVID-19 vaccine donated by the United States.
The doses will be given to those over 18 in four border towns, Tijuana, Mexicali, Ciudad Juárez and Reynosa. The goal is to end essential travel restrictions on the border.
The first vaccinations could be given as early as Wednesday, according to Mexican Assistant Health Secretary Hugo López-Gatell.
Foreign Relations Secretary Marcelo Ebrard, who was meeting with U.S. Homeland Security Secretary Alejandro Mayorkas in Mexico City, said that after the vaccinations “there will be no public health arguments for keeping the border closed.”
The U.S. and Mexico have restricted border crossings to essential travel since early in the pandemic.
Mexico’s vaccination program has used a mix of vaccines and so far, has been focused on people 40 and older. It has administered about 26 million shots, according to the Associated Press.
After an upsurge in December and January, cases have been declining across the country until a spike of 8% this week attributed to a breakout along the Caribbean coast.
Earlier this month, the Biden administration said the U.S. would donate up to 80 million vaccine doses worldwide by the end of the month.
Like these kind of feel good stories? Get the Brighter Side of News' newsletter.
Tags: #Global_Good_News, #Medical_News, #COVID_19, #Vaccines, #The_Brighter_Side_of_News
Joseph Shavit
Science News Writer, Editor-At-Large and Publisher
Joseph Shavit, based in Los Angeles, is a seasoned science journalist, editor and co-founder of The Brighter Side of News, where he transforms complex discoveries into clear, engaging stories for general readers. With experience at major media groups like Times Mirror and Tribune, he writes with both authority and curiosity. His work spans astronomy, physics, quantum mechanics, climate change, artificial intelligence, health, and medicine. Known for linking breakthroughs to real-world markets, he highlights how research transitions into products and industries that shape daily life.